Genetic Variants Associated with Hypospadias: Insights from the Eastern Anatolia Region

Read full text Summarise with VIRAT
Authors: Oğuzhan Yaralı, Muhammet Demir, Hasan Deliağa, Mustafa Can Güler
Cited by: 0
References: 35

Summary

No summary yet. VIRAT can read this paper and write a plain-language summary of its aim, methods, key findings and limitations.

Summarise with VIRAT Free to try with your Science Catalogs account.

Abstract

Objective: This study investigates genetic factors contributing to hypospadias in patients from Eastern Anatolia, aiming to identify pathogenic variants and enhance diagnosis and personalised treatment strategies.Methods: An extensive evaluation was performed on 124 patients diagnosed with hypospadias, incorporating clinical examinations and family history reviews.Next-generation sequencing (NGS) was utilised to evaluate DNA samples, with a focus on 26 genes associated with 46,XY sexual development abnormalities.The genetic variations identified were then categorised according to the standards established by the American College of Medical Genetics (ACMG).This process involved a comparison with 124 healthy individuals who served as a control group.Results: It is notable that the investigation yielded several significant genetic discoveries, comprising probable deleterious mutations in genes such as SRD5A2, MAP3K1, and LHCGR.It is notable that 51 subjects exhibited the homozygous c.265C>G (p.Leu89Val) mutation in the SRD5A2 gene, while 19 patients presented with the heterozygous form.The investigation revealed that neither variant was present in the control group.The variant was thus categorised as a variant of unknown significance (VUS), on the basis of its possible pathogenicity.Furthermore, other VUSs were identified in the SOX9, DYNC2H1, and GATA4 genes. Conclusion:The development of hypospadias is significantly influenced by genetic factors.The present study identified SRD5A2 c.265C>G as a candidate for further functional research, emphasising the significance of genetic analysis in the diagnosis of sexual development abnormalities.Advances in genomic technologies, such as NGS, hold considerable potential in identifying therapeutic targets, thereby enhancing our understanding, diagnosis and treatment of hypospadias.

Fields of Study & Subjects

Urological Disorders and Treatments Sexual Differentiation and Disorders Genomics and Rare Diseases

Publication details

Journal / source
Southern Clinics of Istanbul Eurasia
Pages
10–16
Publication date
1 January 2026
Language
EN